Given that images were acquired during several smaller scale studies, the parameters used .... Lothian birth cohort from 1936: Scotish sample of healthy older.
dž! " #$ % &' " # ' $ (
Age distributions per dataset
MAS LBC−1936 OATS PAFIP−IDIVAL3 SHIP−2 NCNG SHIP−Trend UCLA|NL BP HUBIN STROKEMRI Würzburg|Tübingen HMS NESDA OCD−VUmc Amsterdam 3T OCD−Fukuoka FBIRN OCD−VUmc Amsterdam 1.5T TOP Osaka 1.5T OCD−Barcelona OCD−London MüNC IMpACT OCD−Kunming 1.5T OCD−Kyoto 1.5T OCD−Kyoto 3T OCD−SU UMCU PAFIP−IDIVAL2 TCD|NUIG MCIC CIAM PAFIP−IDIVAL1 OCD−India 3T OCD−India 1.5T OCD−SNU A OCD−Kunming 3T Meth−CT OCD−Shangai BIL & GIN Osaka 3T OCD−SNU C OCD−SNU B CLiNG BIG 1.5T QTIM BIG 3T BP−Houston NeuroIMAGE OCD−Zürich IMAGEN OCD−AMC
20
40
60
80
SupplementaryTableS2:DatasetdescriptionandMRimageacquisitiondetails.OntheleftcolumnarethereferencenumbersasusedinTableI,Figures2,3andSupplementaryMaterialS5. Referencenumber
Dataset
Description
FreeSurferversion
T1acquisitiondetails
1
BIG1.5T
TheBrainImagingGeneticsdatabase,splitbyscannerfieldstrength.A 1.5T(Sonata;Avanto)Siemens population!basedsamplefromNijmegen,theNetherlands
5.3
MRIdatainBIGwereacquiredwitheithera1.5TeslaSiemensSonataorAvantoscannerora3TeslaSiemensTrioorTimTrio scanner(Erlangen,Germany).Giventhatimageswereacquiredduringseveralsmallerscalestudies,theparametersused wereslightvariationsofastandardT1!weightedthree!dimensionalmagnetizationpreparedrapidgradientechosequence (MPRAGE;1.0×1.0×1.0mmvoxelsize).
2
BIG3T
TheBrainImagingGeneticsdatabase,splitbyscannerfieldstrength.A 3T(Trio;TimTrio)Siemens population!basedsamplefromNijmegen,theNetherlands
5.3
MRIdatainBIGwereacquiredwitheithera1.5TeslaSiemensSonataorAvantoscannerora3TeslaSiemensTrioorTimTrio scanner(Erlangen,Germany).Giventhatimageswereacquiredduringseveralsmallerscalestudies,theparametersused wereslightvariationsofastandardT1!weightedthree!dimensionalmagnetizationpreparedrapidgradientechosequence (MPRAGE;1.0×1.0×1.0mmvoxelsize).
3
BIL&GIN
TheBrainimagingoflateralizationstudyatGrouped'Imagerie Neurofonctionnelle,asampleofadultparticipantsenrichedinleft! handers(45%),fromBordeaux,France(Mazoyeretal.,2015)
3T(Achieva)Philips
5.3
3DT1!weightedsequence:3D!FFE!TFE;TR=20ms;TE=4.6ms;flipangle=10°;inversiontime=800ms;turbofieldecho factor=65;sensefactor=2;matrixsize=256x256x180mm3;1mm3isotropicvoxelsize
4
BPHouston
AsubsetofhealthycontrolsfromtheSearchingforEndophenotypes ofBipolarDisordersStudy(BP)
a)3T(Allegra)Siemens(1);b)1.5T(Gyroscan Intera)Philips&c)1.5T(GyroscanIntera) Philips
5.3
a)T1!weightedMPRAGEscans:Flipangle=8°,Echotime(TE)=4.38ms,Repetitiontime(TR)=1750ms,slicethickness=1mm, matrix=256x208,Numberofslices=150. b)T1!weightedspoiledgradientrecalled(SPGR)scans:Flipangle=40°,Echotime(TE)=5ms,Repetitiontime(TR)=24ms,slice thickness=1mm,matrix=256x256,Numberofslices=150. c)T1!weightedSENSE3Dscans:Flipangle=6°,Echotime(TE)=3.6ms,Repetitiontime(TR)=8ms,slicethickness=1mm, matrix= 256x256, Number of slices =150.
5
CIAM
AsubsetofhealthycontrolsfromCorticalInhibitionandAttentional Modulation:astudyofpsychosis(CIAM)!UCT.
3T(Allegra)Siemens
5.3
TR/TE,2300/3.93ms;flipangle,12degrees,FOV,256mm×240mm×160mm;andvoxelsize,1.3mm×1.0mm×1.0mm.
6
CLiNG
AsampleofhealthycontrolsfromClinicalNeuroscienceGöttingen
3T(TrioTim)Siemens
5.3
7
FBIRN
HealthysubjectsfromFunctionBiomedicalInformaticsResearch Network(FBIRN)
a)3T(TimTrio)Siemens&b)3T(Discovery MR750)GE
5.1
8
HMS
HealthysubjectsfromtheHomburgMultidiagnosisStudy
1.5T(Sonata)Siemens
5.3
AT1!weighted,magnetizationpreparedrapidgradientechosequence(MPRAGE)(TR/TE/TI/FA=1900ms/4.0ms/700ms/15°; imagematrix=256x256)wasacquiredgenerating176consecutivesagittalsliceswithavoxelsizeof1mm3.~5min
9
HUBIN
AsampleofhealthysubjectsfromHumanBrainInformatics
1.5T(Signa)GE
4.0
T1!weightedimages,usingathree!dimensionalspoiledgradientrecalled(SPGR)pulsesequence,wereacquiredwiththe followingparameters;1.5mmcoronalslices,nogap,35°flipangle,repetitiontime(TR)>=>24ms,echotime(TE)>=>6.0ms, numberofexcitations(NEX)>=>2,fieldofview(FOV)>=>24cm,acquisitionmatrix>=>256>×>192.
10
IMAGEN
TheImaging!geneticsconsortium,anEuropeaninternational population!basedsample(Schumannetal.,2010)
3T(Achieva)Philips;3TBrucker;3T(TrioTim) Siemens;3T(Verio)Siemens;3T(SignaExcite) Brucker/GE&3T(SignaHDx)GE
4.1
Magneticresonanceimagingdatawereacquiredat8Europeancenters,usingastandardised3Tesla,T1!weightedgradient echoprotocol(voxelsize=1.1mmisotropic)basedonthatfromtheADNIinitiative (http://adni.loni.usc.edu/methods/documents/mri!protocols/)
11
IMpACT
TheInternationalMulticentrepersistentADHDGenetics CollaboraTion:asubsetDutchhealthycontrols
1.5T(Avanto)Siemens
5.3
Allscanshadavoxelsizeof1×1×1mm3,TR2730ms,TI=1000ms,TE2.95ms,176sagittalslices,fieldofview256mm.
12
LBC1936
Lothianbirthcohortfrom1936:Scotishsampleofhealthyolder subjects(age~70)bornon1936,aspartofastudyonbrainagingand 1.5T(SignaHorizonHDx)GE cognition(Wardlawetal.,2011)
4.3
3DIR!PrepT1!weightedwholebrainFSPGRvolumeswereacquiredinthecoronalplaneusingaGESignaHorizonHDxt1.5T clinicalMRIscannerwithmanufacturersuppliedeight!channelphased!arrayheadcoil;FOV=256x256mm,matrix=192x 192,160x1.3mmthickslices,1x1x1.3mmvoxels,TR=10ms,TE=4msandTI=500ms.
13
MAS
Sydney'sMemoryandAgingStudy:anepidemiologicalsampleof europeansubjectshttp://www.ncbi.nlm.nih.gov/pubmed/20637138
5.3
14
MCIC
15
MethCT
16
MüNC
Scanner(s)
3T(AchievaQuasarDualscanner)Phillips
MINDClinicalImagingConsortiumformedbytheMentalIllnessand 1.5TSiemens,3T(Trio)Siemens&3T(Signa) NeuroscienceDiscovery(MIND)InstitutenowtheMindResearch GE Network(MRN;http//ww.mrn.org) Healthycontrolsfromstudiesonmethamphetamineuse;Universityof 3T(MagnetomAllegra)Siemens CapeTown
4.0 5.3 5.3
TheMünsterNeuroimagingCohort
3T(GyroscanIntera),Philips
17
NCNG
TheNorwegianCognitiveNeuroGeneticssample:apopulation!based 1.5T(Sonata)Siemens&1.5T(Avanto) sampleofEuropeansubjects(Espesethetal.,2012) Siemens
4.5
18
NESDA
AsubsetofhealthycontrolsfromtheNetherlandsStudyofDepression 3T(Achieva;Intera)Phillips andAnxiety.
5.0
19
NeuroIMAGE
AsampleofeuropeanhealthycontrolsandhealthysiblingsofADHD patients
1.5T(Sonata),Siemensand1.5T(Avanto), Siemens
AT1!weighted,3Dmagnetizationpreparedrapidgradientechosequence(MPRAGE)(TR/TE/TI/FA=2250ms/3.26ms/900 ms/9°;imagematrix=256x256;duration8minand26sec)wasacquiredgenerating192sagittalsliceswithavoxelsizeof1 mm3. a)MP!RAGEscan:scanplane=sagittal,TR/TE/TI=2300/2.94/1100ms,GRAPPAaccelerationfactor=2,flipangle=9°, resolution=256×256x160,FOV=220mm2,voxelsize=0.86x0.86x1.2mm,andNEX=1. b)IR!SPGRscan:scanplane=sagittal,TR/TE/TI=5.95/1.99/450ms,ASSETaccelerationfactor=2,aflipangle=12°, resolution=256×256x166,FOV=220mm2,voxelsize=0.86x0.86x1.2mm,andNEX=1
3DT1!weightedstructural(T1wTFE–turbofieldecho)MRI,acquiredcoronallywithrepetitiontimeTR=>6.39ms,echotime TE>=>2.9ms,flipangle>=>8°,matrixsize>=>256×256,fieldofviewFOV>=>256×256×190mm3,andslicethickness>=>1mmwith nogapbetween;yielding1×1×1mm3isotropicvoxels TR=2530msfor3T,TR=12msfor1.5T;TE=3.79msfor3T,TE=4.76msfor1.5T;FA=7for3T,FA=20for1.5T;TI= 1100for3T;Bandwidth=181for3T,Bandwidth=110for1.5T;0.625×0.625mmvoxelsize;slicethickness1.5mm;FOV 256×256×128cmmatrix T1!weighted,3D!MEMPRAGEsequence:TR=2530ms;gradedTE=1.53/2.21/4.89/6.57m;flipangle=7°;FOV=256mm;slice thickness=1mm T1!weightedimageswereacquiredusingafastgradientechosequence(turbofieldecho),repetitiontime7.4milliseconds, echotime3.4milliseconds,flipangle9°,acquiredoverafieldofviewof256(feet!head[FH])204(anterior!posterior[AP]) 160(right!left)andreconstructedtocubicvoxelsof.5mm.5mm.5mm[RL])mm ASiemensSonata1.5Teslascanner(Siemens,Erlangen,Germany)withaconventionalheadcoilwasused.Two3DMP!RAGE T1!weightedsequences(duration:8min46s)wererunforallparticipants.Eachvolumeconsistedof128sagittalslices (1.33x1x1mm3),withanin!planevoxelsizeof1mm3(TR=2730ms;TE=3.43ms;TI=1000ms;flipangle=7°;and256×256 matrix).#2:ASiemensAvantoscannerwasusedtoacquiretwo3DMP!RAGET1!weightedsequences(TR/TE/TI/FA=2400 ms/3.61ms/1000ms/8°;matrix=192×192;duration7minand42spervolume).Eachvolumeconsistedof160sagittalslices (1.25×1.25×1.20mm3) ImagingdatawereacquiredattheLeidenUniversityMedicalCenter,AmsterdamMedicalCenter,andUniversityMedical CenterGroningen,equippedwithaSENSE!8(LeidenUniversityMedicalCenterandUniversityMedicalCenterGroningen)or SENSE!6(AmsterdamMedicalCenter)channelheadcoil.Foreachsubject,anatomicalimageswereobtainedusingasagittal 3Dlgradient!echoT1!weightedsequence(TR=9ms,TE=3.5ms;matrix=256x256;voxelsize=1x1x1mm3;170slices; duration=4.5minutes).
5.3
1.5TMRIscannerswereemployed(SiemensSONATAandSiemensAVANTO;Siemens,Erlangen,Germany),usingidentical headcoils(8!channelPhaseArrayHeadCoil).T1!weightedwhole!brainscan(MP!RAGE,176slices,acquisitionmatrix 256x256,voxelsize:1.0x1.0x1.0mm;TE/TR=2.95/2730ms,TI=1000ms,FA=7°;GRAPPA!acceleration2)
5.3
(1)SequencenameT1TFE.In!planeresolution1×1mm.256×256matrix.Slicethickness1.5mmwithoutgap.Numberof slices:150.Orientation:corTR/TE:7.73/3.7msFlipangle:8°.Scanduration:385sec.(2)AcquisitionparametersforT1! weightedstructuralMRIscanswere:TR=6.39ms,TE=2.9ms,flipangle=8°,matrixsize=256x256,FOV=256x256x190,and slicethickness=1mmwithnogapbetween;yielding1x1x1mm3isotropicvoxels(3)in!planeresolution=1×1mm,slice thickness=1.5mm,slicenumber=144,TR(Repetitiontime)=1530ms,TE(Echotime)=3.24ms,TI(Inversiontime)=780ms, flipangle=8andNEX(NumberofExcitations)=1.(4)in!planeresolution=1×1mm,slicethickness=1.5mm,slicenumber=144, TR(Repetitiontime)=1530ms,TE(Echotime)=3.24ms,TI(Inversiontime)=780ms,flipangle=8andNEX(Numberof Excitations)=1.
20
OATS
OneindividualperfamilyofTheOlderAustralianTwinsStudy
1.5T(Gyroscan)Philips;3T(AchievaQuasar Dual)Philips;1.5T(MagnetomAvanto) Siemens;1.5T(Sonata)Siemens
21
OCDAMC
ControlsubjectsfromstudiesonOCD(pedriatric)
3T(Intera)Philips
5.3
3T(PhilipsInteraMR)matrix256x256,182slices,voxelsize1x1x1.2mm
22
OCDBarcelona
ControlsubjectsfromstudiesonOCD
1.5T(SignaExcite)GE
5.3
matrix256x256,130slices,voxelsize1.2x1.2x1.2mm
23
OCDFukuoka
ControlsubjectsfromstudiesonOCD
3T(AchievaTX)Philips
5.3
3T(PhilipsAchievaTX)matrix240x240,TR8.2ms,TE3.8ms,TI(inversiontime)240ms,Flipangle8degree,FOV240x240,NSA 1,Slicetickness1mm,numberofslice190,voxelsize1.8x1.8.1.8mm,scantime320s
24
OCDIndia1.5T
5.3
1.5T(SiemensVision):matrix256x256,160slices,0.98x0.98x1mm
25
OCDIndia3T
5.3
3T(SiemensSkyra):matrix256X256,192slices,voxelsize1.0X1.0X1.0mm;
26
OCDKunming1.5T
ControlsubjectsfromstudiesonOCD
1.5T(SignaExcite)GE
5.3
1.5T(SignaExcite)GE:matrix256x256,172slices,voxelsize0.93x0.93x0.9mm
27
OCDKunming3T
ControlsubjectsfromstudiesonOCD
3T(Achieva)Philips
5.3
3T(Achieva)Philips:matrix228x228,230slices,FOV=250,voxelsize1.1x1.1x0.6mm
28
OCDKyoto1.5T
ControlsubjectsfromstudiesonOCD
1.5T(GyroscanIntera)Philips
5.3
Three!dimensionalvolumetricacquisitionofaT1!weightedgradientechosequenceproducedagaplessseriesofcontiguous, thinsagittalsectionswiththefollowingparameters:flipangle,15°;acquisitionmatrix,256×256;fieldofview,25cm;section thickness,1.5mm;voxelsize,0.98mm×0.98mm×1.5mm;TR,9.9ms;TE,5.8ms.
29
OCDKyoto3T
ControlsubjectsfromstudiesonOCD
3T(Achieva3.0TX)Philips
5.3
ThescanningparametersoftheT1!weightedthree!dimensionalmagnetization!preparedrapidgradient!echo(3D!MPRAGE) sequenceswereasfollows:flipangle,10degrees;acquisitionmatrix,256x256x170;fieldofview,25.6cm;sectionthickness, 1.0mm;voxelsize,1.0mmx1.0mmx1.0mm;TR,7.1ms;andTE,3.3ms.
30
OCDLondon
ControlsubjectsfromstudiesonOCD
1.5T(Signa)GEand1.5T(SignaHDx)GE
5.3
31
OCDShanghai
ControlsubjectsfromstudiesonOCD
3T(Verio)Siemens
5.3
32
OCDSNUA
ControlsubjectsfromstudiesonOCD
1.5T(Signa)GE
5.3
33
OCDSNUB
ControlsubjectsfromstudiesonOCD
1.5T(Avanto)Siemens
5.3
34
OCDSNUC
ControlsubjectsfromstudiesonOCD
3T(MagnetomTrio)SIemens
5.3
35
OCDSU
ControlsubjectsfromstudiesonOCD
3T(MagnetomAllegra)Siemens
36
OCDVUmcAmsterdam1.5T
ControlsubjectsfromstudiesonOCD
1.5T(Sonata)Siemens
5.3
1.5T(SiemensSonata)matrix256x256,160slices,voxelsize1x1x1.5mm
37
OCDVUmcAmsterdam3T
ControlsubjectsfromstudiesonOCD
3T(SignaHDxt)GE
5.3
3T(SignaHDxt)matrix256x256,172slices,voxelsize1x0.977x0.977mm
38
OCDZurich
Healthycontrolsubjects(adolescentsandadults)
3T(Achieva)Philips
5.3
3T(PhilipsAchieva)matrix240x240,160slices,voxelsizeisotropic1x1x1mm,TR8.14ms,TE3.7ms,Flipangle8degree
39
Osaka1.5T
ControlsubjectsfromtheJapaneseOsakacase!controlstudiesof schizophrenia
1.5T(Signa)GE&3T(SignaHDxt)GE
5.3
T1!weightedIR!FSPGRsagittal3Dvolume(TR=12.6ms;TE=4.2ms;TI=400ms;124slices,matrixsize=256x256, FOV=24.0x24.0cm2,voxelsize=0.9375x0.9375x1.4mm3,slicethickness=1.4mm,flipangle=15°)T1!weightedIR!FSPGR sagittal3Dvolume(TR=7.2ms;TE=2.9ms;TI=400ms;172slices,matrixsize=256x256x172,FOV=24.0x24.0cm2,voxel size=0.9375x0.9375x1.0mm3,slicethickness=1.0mm,flipangle=11°)
40
Osaka3T
ControlsubjectsfromtheJapaneseOsakacase!controlstudiesof schizophrenia
1.5T(Signa)GE&3T(SignaHDxt)GE
5.3
T1!weightedIR!FSPGRsagittal3Dvolume(TR=12.6ms;TE=4.2ms;TI=400ms;124slices,matrixsize=256x256, FOV=24.0x24.0cm2,voxelsize=0.9375x0.9375x1.4mm3,slicethickness=1.4mm,flipangle=15°)T1!weightedIR!FSPGR sagittal3Dvolume(TR=7.2ms;TE=2.9ms;TI=400ms;172slices,matrixsize=256x256x172,FOV=24.0x24.0cm2,voxel size=0.9375x0.9375x1.0mm3,slicethickness=1.0mm,flipangle=11°)
41
PAFIPIDIVAL1
Healthycontrolsfromstudiesonschizofrenia
1.5T(Signa)GE
5.0
T1!weightedimages,usingaspoiledgrass(SPGR)sequence,wereacquiredinthecoronalplanewiththefollowing parameters:TE=5ms,TR=24ms,NEX=2,FA=45o,FOV=26x19.5cm,slicethickness=1.5mmandamatrixof256x192
42
PAFIPIDIVAL2
Healthycontrolsfromstudiesonschizofrenia
3T(Achieva)Phillips
5.3
SagittalT1,TR=3000ms;TE=4.6ms;FA=8o;Voxelsize=1x1x1mm;Slicethickness=1mm;Matrixsize=321x312
43
PAFIPIDIVAL3
Healthycontrolsfromstudiesonschizofrenia
1.5T(Signa)GE
5.0
T1!weightedimages,usingaspoiledgrass(SPGR)sequence,wereacquiredinthecoronalplanewiththefollowing parameters:TE=5ms,TR=24ms,NEX=2,FA=45o,FOV=26x19.5cm,slicethickness=1.5mmandamatrixof256x192
44
QTIM
Anaselectsubsetoftwin!singletonsofeuropeandescentfromThe QueenslandTwinImagingstudy.
4T(Bruker)Medspec
5.3
1.5T(Avanto)Siemens
5.1
1.5T(Avanto)Siemens
5.1
Healthycontrols,examinedusingastructuredinterviewtoruleouta 1.5T(Vison)Siemens psychiatricdiagnosisorneurologicaldisease Healthycontrols,examinedusingastructuredinterviewtoruleouta 3T(Skyra)Siemens psychiatricdiagnosisorneurologicaldisease
PopulationbasedsamplefromTheStudyofhealthinPomerania (north!easternGermany) PopulationbasedsamplefromTheStudyofhealthinPomerania (north!easternGermany)
5.3
Sequence1:3DSPGR,TR:14.8ms,TE:1.7ms,FA:20º,Orientation:Axial,Matrixsize:256x256x124,Voxelsize:0.94x0.94x 1.50;Sequence2:3DSPGR,TR:10.8ms,TE:5.0ms,FA:18º,Orientation:Axial,Matrixsize:256x256x146,Voxelsize:1.09x 1.09x1.10 3T(Siemensverio)matrix256x256,192slices,slicetickness1.0mm,voxelsize1x1x1mm,TR2300ms,TE2.96ms,FOV 256x240,flipangle9degree MPRAGEsequencewereacquiredin176contiguousaxialslices:TR/TE=1160/4.76ms,fieldofview=23cm,flipangle=15°, matrix416x512,voxelsize0.45x0.45x0.90mm. Contiguous1.5!mmsagittalimageswereobtainedwithathree!dimensionalT1!weightedspoiledgradient!echosequence (echotime=5.5ms;repetitiontime=14.4ms;flipangle=20°;fieldofview=21×21cm;matrix256x256;voxelsize 0.82x0.82x1.50mm). High!resolutionT1!weighted,three!dimensionalMPRAGE(TR=670ms;TE=1.89ms;FOV=50mm;FA=9°;matrix256x256; voxelsize1.000x0.977x0.977mm). T1!weightedMPRAGEsagittal3Dvolume(TR=2300ms;TE=3.93ms;TI=1100ms;160slices;FOV=256x240mm;voxel size=1.3x1.0x1.0mm3;slicethickness=1mm,flipangle=12degrees
Scanswerecollectedona4TeslaBrukerMedspecscanner(Bruker,Germany).T1!weightedstructuralscanswereacquired withacquisitionparameters:TR=1500ms,TE=3.35ms,TI=700ms,flipangle=8°,256or240(coronalorsagittal)slices, FOV=240mm,acquisitionvoxelsize1.1x0.9x0.9mm. 3DT1!weightedMRIsequencewiththefollowingparameters:MP!RAGE/axialplane,TR=1900ms,TE=3.4msandFlip angle=15°andanoriginalresolutionof1.0x1.0x1.0mm3 3DT1!weightedMRIsequencewiththefollowingparameters:MP!RAGE/axialplane,TR=1900ms,TE=3.4msandFlip angle=15°andanoriginalresolutionof1.0x1.0x1.0mm3 SagittalT1!weightedFSPGRsequence(TE:2.956,TR:7.8ms,flipangle:12degrees,voxelsixe=1x1x1.2millimeter,number ofslices:166) TCD:T1!weightedTFEgradientecho(TE(ms)3.8;TR(ms)8.4;Flipangle( )8;FOV230;Matrix256x256;No.slices180; slicethickness(mm)0.9;Voxel!size(mm3)0.9x0.9x0.9);NUIG:1.5T:T1!weightedMP!RAGE(TE(ms)4.38;TR(ms)1140; Flipangle(°)15;FOV230;Matrix512x512(k!spaceinterpolationfrom256x256);No.slices160;slicethickness(mm)0.9; Voxel!size(mm3)0.45x0.45x0.9) TwosagittalT1!weightedmagnetizationpreparedrapidgradientecho(MPRAGE)volumeswereacquiredwiththeSiemens tfl3d1_nspulsesequence(TE=3.93ms,TR=2730ms,TI=1000ms,flipangle=7°;FOV=24cm,voxelsize=1.33x0.94x1 mm3,numberofpartitions=160)
45
SHIP2
46
SHIPT
47
STROKEMRI
Healthycontrolsfromanongoingstrokestudy,Oslo
3T(HDxT)GE
48
TCD|NUIG
HealthysubjectsfromTCD(Dublin)andNUIG(Galway)
TCD:3T(Intera)Philips;NUIG:1.5T (Magnetom),Siemens
49
TOP
ControlsubjectsfromTematiskOmrådePsykoser(Thematically OrganizedPsychosisResearch)
50
UCLA|NLBP
HealthycontrolsfromtheBipolarGeneticsdataset.ThisNIMH!funded studyiscarriedoutattheUniversityMedicalCenterUtrecht,the Netherlands,inacollaborationwiththeUniversityofCaliforniaLos 3T(Achieva)Philips Angeles
5.1
Three!dimensionalT1!weightedimageswereacquiredona3TeslaPhilipsAchievascanner(PhilipsHealthcare,Best,the Netherlands),equippedwithan8!channelSENSE!headcoil.Fastfieldechoscanswith200contiguoussagittalslices(TE=4.6 ms,TR=10ms,flipangle=8@,FOV=240mm,0.75x0.75x0.80mm³voxels)wereobtained.
51
UMCU
Healthycontrolsfromtwoindependentschizophreniacohorts recruitedattheUniversityMedicalCentreUtrecht,theNetherlands
5.1
AThree!Dimensional!FastFieldEcho(3D!FFE)ona1.5TPhilipsAchievascanner:TE=4.6ms,TR=30ms,flipangle=30°, FOV=256x256mm2)with160!180contiguouscoronal1.2mmslices
52
Würzburg|Tübingen
DatasetofhealthycontrolsfromastudyonADHD
5.3
Ahigh!resolutionT1!weightedmagnetization!preparedrapidgradient!echoimaging(MP!RAGE)3DMRIsequencewas obtainedfromeachparticipant(TR:2250ms,TE:3.93ms,8°flipangle,FOV:256mm,matrix:256×256,voxelsize:1×1×1mm3
1.5T(Sonata)Siemens
1.5T(Achieva)Philips
1.5T(Avanto)Siemens
5.3
TCD:5.3NUIG:5.1
5.3
SupplementalInformationS3.Listofdatasets(arrangedalphabetically)onwhichhandednessanalyseswereperformed, correspondingsamplesizesandassessmentmethods.
Left
Right
handed
handed
BIG1.5T
67
1205
Self!report
BIG3T
56
1150
Self!report
BIL&GIN
205
248
Self!report
CLiNG
15
307
SelfreportconfirmedbyEdinburghHandednessInventory
FBIRN
5
173
Self!report
Dataset
Assessment
HMS
7
44
SelfreportconfirmedbyEdinburghHandednessInventory
HUBIN
6
90
Self!report
IMAGEN
160
1391
SelfreportconfirmedbyPurduePegboardtest
IMpACT
15
126
Self!report
LBC1936
34
522
Writinghand
MCIC
9
154
AnnettScaleofHandPreference
14
729
MüNC
EdinburghHandednessInventory:Athresholdof12(outof14)itemswasusedto categorizeasleft!orright!handed.
NCNG
26
301
Self!report
NESDA
5
61
Self!report
NeuroIMAGE
45
333
Self!report
OCDVUmcAmsterdam1.5T
6
48
Self!report
OCDVUmcAmsterdam3T
7
31
Self!report
Osaka1.5T
28
409
SelfreportconfirmedbyEdinburghHandednessInventory
Osaka3T
11
226
SelfreportconfirmedbyEdinburghHandednessInventory
SHIP2
57
1053
Self!report
SHIPTrend
97
1943
Self!report
STROKEMRI
6
46
Self!report
TOP
22
279
Self!report
UCLA|NLBP
20
140
Self!report
UMCU
36
227
Self!report
SupplementalInformationS4:Left!rightflipchecks
Ofspecialimportancewastoassurethecorrectcorrespondencebetweentheleft/rightorientationoftheprocessed imagedataandtheoriginalsubjectspace.Incontrasttotheotheraxes(antero!posteriororsuperior!inferior),the correctorientationontheleft!rightaxisisnotdirectlyidentifiablefromvisualfeatures,makingitdifficulttoreadily detectanyerroneousimageflipsduringprocessing.Suchproblemsaremuchmoreunlikelysincetheadoptionofthe niftiimagingstandard(http://nifti.nimh.nih.gov/),buttheycanstillbeapotentialsourceofartifactiftheraw(often DICOM!formatted)dataisprocessedwithincorrectassumptions(SPMdocumentation,p.157; http://www.fil.ion.ucl.ac.uk/spm/doc/manual.pdf).
BecausetheENIGMAprotocolstartsaftertheraw(oftenDICOM!formatted)datahasbeenconvertedintoanimaging standard(orconvertedbyFreeSurferitself),thismeantthatconversionfromtheDICOMformatwasthemostlikely stepwhereanyerrorcouldhavetakenplace.Thiswasassessedusingseveralstrategies,dependingontheavailable informationateachsite.TheBIL&GIN,FBIRN,MAS,NESDAandOATSsampleshadmadeuseofparamagneticfiducial markersonasubsetoftheirsubjects,thuseliminatingorientationambiguity.InQTIMandSHIP,subjectswithaknown unilateralbrainabnormalitywereusedtocheckthecorrectorientationoftheimageafterconversion.InBIG,CLiNG, HMSandOCDSU,afewexamplesweremanuallycheckedformismatchesbetweentheDICOMandniftiheader information,i.e.acorrectflipfrom'radiological'to'neurological'orientation.Finally,wecheckedtheconsistency betweenseveral,commonlyused,DICOMtonifticonversiontoolsandDICOMimagesgeneratedfromdifferent manufacturers/models(usingexamplesdownloadedfromthemanufacturer'swebsites).Theconvertorsusedinthis stepwere:"mri_convert"(https://surfer.nmr.mgh.harvard.edu/pub/docs/html/mri_convert.help.xml.html)," MRIConvert"(http://lcni.uoregon.edu/downloads/mriconvert),"dcm2nii" (http://www.cabiatl.com/mricro/mricron/dcm2nii.html)and"spm_dicom_convert"(http://www.fil.ion.ucl.ac.uk/spm/).
Giventhatthesechecksyieldednoproblems,andthatthedatasetswherenoerrorwasdetectedcomprised60%ofthe totalmeta!analysissample,wewereconfidentthatsuchorientationerrorsmusthavebeenveryunlikely.
Supplementary Information S5. Plots of the relationship between ICV and subcortical AIs in the BIG 3T sample. Regression analyses of linear and quadratic relationships revealed only linear effects of ICV with AIs of the nucleus accumbens, caudate nucleus and putamen (as indicated by the dashed lines).
0.1 −0.1 −0.3
Accumbens AI
N. accumbens AI against ICV
1000000
1200000
1400000
1600000
1800000
2000000
2200000
2000000
2200000
2000000
2200000
2000000
2200000
ICV
0.05 −0.15 −0.05
Amygdala AI
0.15
Amygdala AI against ICV
1000000
1200000
1400000
1600000
1800000
ICV
0.10 0.00
Thalamus AI
Thalamus AI against ICV
1000000
1200000
1400000
1600000
1800000
ICV
0.05 −0.05 0.00
Caudate AI
Caudate N. AI against ICV
1000000
1200000
1400000
1600000 ICV
1800000
0.05 −0.05
Putamen AI
Putamen AI against ICV
1000000
1200000
1400000
1600000
1800000
2000000
2200000
2000000
2200000
2000000
2200000
ICV
0.1 0.0 −0.2
Globus pallidus AI
Globus Pallidus AI against ICV
1000000
1200000
1400000
1600000
1800000
ICV
0.05 −0.05
Hippocampus AI
Hippocampus AI against ICV
1000000
1200000
1400000
1600000 ICV
1800000
Supplementary Information S6. Boxplots of AI distributions for each dataset and structure. For each structure, the datasets are ordered top-to-bottom by their median AIs. The identities of the datasets are given by the numbers in the lefthand columns, with reference to Table 1. The horizontal length of each box represents the 2nd to 3rd quartile of the AI distribution (i.e. containing half of subjects in each dataset) and split at the median AI. The vertical width of each dataset's box is proportional to the square root of its sample size. The whiskers show the minimum and maximum values (curtailed in cases where the outer box boundary was reached). The vertical dotted lines indicate the points of perfect symmetry, AI=0.
N. accumbens
16 2 23 50 10 6 43 13 9 42 25 21 35 44 34 7 28 1 33 37 14 18 47 41 40 24 20 15 52 31 5 30 4 8 19 51 49 22 12 36 39 38 32 17 26 46 3 45 29 27 11 48
Amygdala
47 27 43 38 26 36 12 50 42 29 37 3 39 13 23 22 15 18 5 4 45 20 51 10 17 46 8 33 14 28 41 30 7 24 1 9 44 11 52 49 19 31 34 6 48 16 35 2 25 32 40 21
−0.3
0.0
0.2
Caudate N.
3 5 21 19 13 26 36 15 22 27 11 48 20 17 29 12 43 44 42 47 6 30 8 37 50 51 49 4 1 38 10 23 45 31 46 9 7 18 2 16 39 35 33 14 41 52 25 24 32 34 28 40
−0.2
0.0
0.2
Globus pallidus
26 47 13 25 31 43 37 16 27 34 2 1 29 39 48 52 40 23 42 30 4 20 3 24 12 36 33 14 22 38 8 28 11 19 50 44 9 17 41 32 51 5 10 18 46 45 21 7 15 49 35 6
−0.10
0.00
0.10
Hippocampus
47 8 37 48 25 12 13 22 4 31 21 28 11 34 19 6 24 46 36 45 50 39 40 9 32 20 33 5 1 17 41 35 10 42 49 2 43 51 14 18 29 23 15 30 52 16 38 27 7 3 26 44
34 27 31 37 40 38 28 26 50 18 15 29 42 14 36 5 23 17 45 20 33 48 32 35 49 10 46 13 25 44 11 9 24 7 22 21 39 8 6 4 2 1 12 3 52 41 43 30 19 51 16
−0.2
0.0
0.2
Putamen
−0.10
0.00
0.10
Thalamus
41 46 7 45 3 21 12 17 10 49 11 50 5 22 18 35 32 15 26 48 30 9 6 36 20 16 51 27 19 44 8 14 4 33 38 23 40 52 42 24 34 39 2 1 43 37 28 31 25 29 13 47
−0.10
0.05
0.15
−0.05 0.05
0.15
Supporting Information S7. Meta-analyzed results from testing population-level lateralization (mean AI's ≠ 0) separately by sex. A positive Z-score indicates leftward asymmetry in volume (L>R), while a negative Z-score reflects a rightward asymmetry (R>L).
Females
N
z-score
Nucleus accumbens
7957
-11.01
Amygdala
8049
Caudate nucleus
Males
N
z-score
Nucleus accumbens
7053
-4.80
-33.36
Amygdala
7118
-32.72
7980
-34.92
Caudate nucleus
7125
-31.12
Globus pallidus
7892
23.61
Globus pallidus
7040
31.16
Hippocampus
7971
-22.67
Hippocampus
7075
-20.14
Putamen
7920
59.86
Putamen
7041
53.16
Thalamus
8043
41.43
Thalamus
7115
33.44
Phenotype 1
Phenotype 2
Phenotype correlation AI_amygdala AI_accumbens 0.00 AI_amygdala AI_caudate 0.10 AI_amygdala AI_hippocampus 0.00 AI_amygdala AI_pallidum 0.03 AI_amygdala AI_putamen 0.09 AI_amygdala AI_thalamus -0.06 AI_caudate AI_accumbens -0.08 AI_caudate AI_hippocampus -0.03 AI_caudate AI_pallidum 0.05 AI_caudate AI_putamen 0.12 AI_caudate AI_thalamus 0.04 AI_hippocampus AI_accumbens 0.00 AI_hippocampus AI_pallidum 0.02 AI_hippocampus AI_putamen 0.01 AI_hippocampus AI_thalamus 0.11 AI_pallidum AI_accumbens 0.07 AI_pallidum AI_putamen 0.05 AI_pallidum AI_thalamus -0.21 AI_putamen AI_accumbens -0.02 AI_putamen AI_thalamus -0.26 AI_thalamus AI_accumbens -0.05
Phenotype correlation P 0.90028 0.0001192 0.9357421 0.2340173 0.0005557 0.0209367 0.0040859 0.3293978 0.0393021 4.46E-06 0.1032485 0.9842037 0.4847126 0.7405954 3.29E-05 0.0068105 0.0446912 7.16E-16 0.4199311 8.26E-23 0.0873988
Genetic correlation -0.99 0.85 -0.81 -0.42 0.13 -0.10 0.32 -0.36 -0.11 -0.14 0.31 -0.11 0.10 0.04 0.10 0.18 -0.12 -0.26 -0.61 -0.48 -0.14
Genetic correlation P 0.0126487 0.0914741 0.0356209 0.3471581 0.716055 0.7943838 0.3575671 0.2211863 0.752416 0.6170061 0.3141842 0.6521278 0.6775807 0.8433021 0.6507085 0.5735795 0.6430572 0.3783415 0.0202141 0.0365587 0.6142865
Supplementary Information S8. Phenotypic and genetic correlations among AIs in the GOBS dataset.